By inhibiting GPX4, RSL3 disrupts the cellular defense mechanisms against lipid peroxidation, leading to the accumulation of toxic lipid peroxides and subsequent initiation of ferroptosis in cancer cells (180). Here, GPX4 is linked to cancer.